4x1v - Revision history

OCA at 11:28, 9 May 2024

2024-05-09T11:28:51Z

←Older revision		Revision as of 11:28, 9 May 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4X1V FirstGlance]. <br>		<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4X1V FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [https://pdbe.org/4x1v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [https://www.ebi.ac.uk/pdbsum/4x1v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4x1v ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.58Å</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [https://pdbe.org/4x1v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [https://www.ebi.ac.uk/pdbsum/4x1v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4x1v ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 21:07, 12 April 2023

2023-04-12T21:07:10Z

←Older revision		Revision as of 21:07, 12 April 2023
Line 3:		Line 3:
	<StructureSection load='4x1v' size='340' side='right'caption='[[4x1v]], [[Resolution\|resolution]] 1.58Å' scene=''>		<StructureSection load='4x1v' size='340' side='right'caption='[[4x1v]], [[Resolution\|resolution]] 1.58Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4X1V FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4X1V FirstGlance]. <br>
-	</td></tr>~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3u23\|3u23]], [[4wci\|4wci]]</td></tr>~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [https://pdbe.org/4x1v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [https://www.ebi.ac.uk/pdbsum/4x1v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4x1v ProSAT]</span></td></tr>
-	~~<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CD2AP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>~~	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [~~http~~://pdbe.org/4x1v PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4x1v PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4x1v ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Defects in CD2AP are the cause of susceptibility to focal segmental glomerulosclerosis type 3 (FSGS3) [MIM:[~~http~~://omim.org/entry/607832 607832]]. A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and edema. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.<ref>PMID:12764198</ref>	+	[https://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN] Defects in CD2AP are the cause of susceptibility to focal segmental glomerulosclerosis type 3 (FSGS3) [MIM:[https://omim.org/entry/607832 607832]. A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and edema. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.<ref>PMID:12764198</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell. May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis.<ref>PMID:15800069</ref> [[http://www.uniprot.org/uniprot/ARAP1_HUMAN ARAP1_HUMAN]] Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity).<ref>PMID:11804590</ref>	+	[https://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN] Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell. May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis.<ref>PMID:15800069</ref>

	==See Also==		==See Also==
Line 19:		Line 17:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Arrowsmith~~, C H~~]]	+	[[Category: Arrowsmith CH]]
-	[[Category: Bountra, C]]	+	[[Category: Bountra C]]
-	~~[[Category: Delft, F von~~]]	+	[[Category: Edwards AM]]
-	[[Category: Edwards~~, A M~~]]	+	[[Category: Feller SM]]
-	[[Category: Feller~~, S M~~]]	+	[[Category: Kirsch KH]]
-	[[Category: Kirsch~~, K H~~]]	+	[[Category: Knapp S]]
-	[[Category: Knapp, S]]	+	[[Category: Krojer T]]
-	[[Category: Krojer, T]]	+	[[Category: Rouka E]]
-	[[Category: Rouka, E]]	+	[[Category: Simister PC]]
-	[[Category: Simister~~, P C~~]]	+	[[Category: Von Delft F]]
-	[[Category: ~~Endocytosis adaptor protein]]~~	+
-	~~[[Category: Kidney]]~~	+
-	~~[[Category: Protein-peptide binary complex]]~~	+
-	~~[[Category: Sgc]]~~	+
-	~~[[Category: Signaling protein]]~~	+
-	~~[[Category: Structural genomic~~]]	+

OCA at 08:27, 23 May 2019

2019-05-23T08:27:47Z

←Older revision		Revision as of 08:27, 23 May 2019
Line 1:		Line 1:

	==Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1==		==Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1==
-	<StructureSection load='4x1v' size='340' side='right' caption='[[4x1v]], [[Resolution\|resolution]] 1.58Å' scene=''>	+	<StructureSection load='4x1v' size='340' side='right'caption='[[4x1v]], [[Resolution\|resolution]] 1.58Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X1V FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X1V FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3u23\|3u23]], [[4wci\|4wci]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3u23\|3u23]], [[4wci\|4wci]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [http://pdbe.org/4x1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [http://www.ebi.ac.uk/pdbsum/4x1v PDBsum]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CD2AP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [http://pdbe.org/4x1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [http://www.ebi.ac.uk/pdbsum/4x1v PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4x1v ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 11:		Line 12:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell. May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis.<ref>PMID:15800069</ref> [[http://www.uniprot.org/uniprot/ARAP1_HUMAN ARAP1_HUMAN]] Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity).<ref>PMID:11804590</ref>		[[http://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell. May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis.<ref>PMID:15800069</ref> [[http://www.uniprot.org/uniprot/ARAP1_HUMAN ARAP1_HUMAN]] Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity).<ref>PMID:11804590</ref>
		+
		+	==See Also==
		+	*[[CD2-associated protein 3D structures\|CD2-associated protein 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Arrowsmith, C H]]		[[Category: Arrowsmith, C H]]
	[[Category: Bountra, C]]		[[Category: Bountra, C]]

OCA at 10:21, 26 February 2016

2016-02-26T10:21:21Z

←Older revision		Revision as of 10:21, 26 February 2016
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X1V FirstGlance]. <br>		<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X1V FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [http://pdbe.org/4x1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [http://www.ebi.ac.uk/pdbsum/4x1v PDBsum]</span></td></tr>	+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3u23\|3u23]], [[4wci\|4wci]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [http://pdbe.org/4x1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [http://www.ebi.ac.uk/pdbsum/4x1v PDBsum]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 02:48, 21 February 2016

2016-02-21T02:48:12Z

←Older revision		Revision as of 02:48, 21 February 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 4x1v ~~is ON HOLD~~	+	==Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1==
-		+	<StructureSection load='4x1v' size='340' side='right' caption='[[4x1v]], [[Resolution\|resolution]] 1.58Å' scene=''>
-	~~Authors~~: ~~Rouka, E~~.~~, Krojer, T~~.~~, von Delft, F~~.~~, Knapp, S~~.~~, Kirsch, K~~.H.~~, Arrowsmith, C~~.H., ~~Edwards, A~~.M., ~~Bountra, C~~., ~~Feller, S~~.M., ~~Simister, P~~.C.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4x1v]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4X1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4X1V FirstGlance]. <br>
-	~~Description~~: ~~Crystal structure of the 2nd SH3 domain from human~~ CD2AP (~~CMS~~) in ~~complex with~~ a ~~proline~~-~~rich peptide~~ (~~aa 76~~-91) ~~from human ARAP1~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4x1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4x1v OCA], [http://pdbe.org/4x1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4x1v RCSB], [http://www.ebi.ac.uk/pdbsum/4x1v PDBsum]</span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	</table>
-	[[Category: ~~Arrowsmith~~, C.H]]	+	== Disease ==
-	[[Category: ~~Feller~~, S.M]]	+	[[http://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Defects in CD2AP are the cause of susceptibility to focal segmental glomerulosclerosis type 3 (FSGS3) [MIM:[http://omim.org/entry/607832 607832]]. A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and edema. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.<ref>PMID:12764198</ref>
-	[[Category: ~~Kirsch~~, ~~K.H~~]]	+	== Function ==
-	[[Category: ~~Von Delft~~, F]]	+	[[http://www.uniprot.org/uniprot/CD2AP_HUMAN CD2AP_HUMAN]] Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell. May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis.<ref>PMID:15800069</ref> [[http://www.uniprot.org/uniprot/ARAP1_HUMAN ARAP1_HUMAN]] Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity).<ref>PMID:11804590</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Arrowsmith, C H]]
		+	[[Category: Bountra, C]]
		+	[[Category: Delft, F von]]
		+	[[Category: Edwards, A M]]
		+	[[Category: Feller, S M]]
		+	[[Category: Kirsch, K H]]
	[[Category: Knapp, S]]		[[Category: Knapp, S]]
-	[[Category: ~~Simister~~, ~~P.C~~]]	+	[[Category: Krojer, T]]
	[[Category: Rouka, E]]		[[Category: Rouka, E]]
-	[[Category: ~~Edwards~~, ~~A.M~~]]	+	[[Category: Simister, P C]]
-	[[Category: ~~Krojer, T~~]]	+	[[Category: Endocytosis adaptor protein]]
-	[[Category: ~~Bountra, C~~]]	+	[[Category: Kidney]]
		+	[[Category: Protein-peptide binary complex]]
		+	[[Category: Sgc]]
		+	[[Category: Signaling protein]]
		+	[[Category: Structural genomic]]

OCA at 23:03, 30 November 2015

2015-11-30T23:03:39Z

←Older revision		Revision as of 23:03, 30 November 2015
Line 7:		Line 7:
	Description: Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1		Description: Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
		+	[[Category: Arrowsmith, C.H]]
	[[Category: Feller, S.M]]		[[Category: Feller, S.M]]
	[[Category: Kirsch, K.H]]		[[Category: Kirsch, K.H]]
		+	[[Category: Von Delft, F]]
	[[Category: Knapp, S]]		[[Category: Knapp, S]]
	[[Category: Simister, P.C]]		[[Category: Simister, P.C]]
	[[Category: Rouka, E]]		[[Category: Rouka, E]]
		+	[[Category: Edwards, A.M]]
	[[Category: Krojer, T]]		[[Category: Krojer, T]]
	[[Category: Bountra, C]]		[[Category: Bountra, C]]
-	[[Category: Arrowsmith, C.H]]
-	[[Category: Von Delft, F]]
-	[[Category: Edwards, A.M]]

OCA at 20:20, 24 December 2014

2014-12-24T20:20:55Z

←Older revision		Revision as of 20:20, 24 December 2014
Line 6:		Line 6:

	Description: Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1		Description: Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1
		+	[[Category: Unreleased Structures]]
		+	[[Category: Feller, S.M]]
		+	[[Category: Kirsch, K.H]]
		+	[[Category: Knapp, S]]
		+	[[Category: Simister, P.C]]
		+	[[Category: Rouka, E]]
		+	[[Category: Krojer, T]]
		+	[[Category: Bountra, C]]
		+	[[Category: Arrowsmith, C.H]]
		+	[[Category: Von Delft, F]]
		+	[[Category: Edwards, A.M]]

OCA: Protected "4x1v" [edit=sysop:move=sysop]

2014-12-03T08:46:01Z

Protected "4x1v" [edit=sysop:move=sysop]

←Older revision

Revision as of 08:46, 3 December 2014

OCA: New page: '''Unreleased structure''' The entry 4x1v is ON HOLD Authors: Rouka, E., Krojer, T., von Delft, F., Knapp, S., Kirsch, K.H., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Feller, S.M., ...

2014-12-03T08:46:00Z

New page: '''Unreleased structure''' The entry 4x1v is ON HOLD Authors: Rouka, E., Krojer, T., von Delft, F., Knapp, S., Kirsch, K.H., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Feller, S.M., ...

New page

'''Unreleased structure'''

The entry 4x1v is ON HOLD

Authors: Rouka, E., Krojer, T., von Delft, F., Knapp, S., Kirsch, K.H., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Feller, S.M., Simister, P.C.

Description: Crystal structure of the 2nd SH3 domain from human CD2AP (CMS) in complex with a proline-rich peptide (aa 76-91) from human ARAP1